Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 500 participants.

Also called NCT05591118

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05591118
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05591118. Randomized; no masking; primary purpose treatment. Start 2023-07-17 (actual); primary completion 2027-03-29 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
Acronym
PE-TRACT
Intervention (Drug)
Anticoagulant Therapy
Intervention (Device)
Catheter-Directed Therapy
Lead sponsor
NYU Langone Health (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05591118
Content hash
4d8623d8d7938c453753e961b49387115850f1a20ca44379cde20f4aa43ebb36